IRIS
PUGLISI, Fabio
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 22.985
AS - Asia 11.554
EU - Europa 6.442
SA - Sud America 2.110
AF - Africa 260
Continente sconosciuto - Info sul continente non disponibili 25
OC - Oceania 16
Totale 43.392
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 22.653
SG - Singapore 5.681
CN - Cina 2.199
BR - Brasile 1.702
UA - Ucraina 1.277
HK - Hong Kong 1.167
VN - Vietnam 1.052
DE - Germania 951
IT - Italia 940
RU - Federazione Russa 592
FI - Finlandia 580
FR - Francia 509
SE - Svezia 354
IN - India 346
IE - Irlanda 318
GB - Regno Unito 316
TR - Turchia 200
CA - Canada 186
KR - Corea 148
AR - Argentina 147
BD - Bangladesh 129
NL - Olanda 93
PL - Polonia 86
JP - Giappone 85
AT - Austria 82
MX - Messico 82
IQ - Iraq 76
ID - Indonesia 67
ZA - Sudafrica 66
EC - Ecuador 64
BE - Belgio 58
PK - Pakistan 57
ES - Italia 54
CO - Colombia 53
CZ - Repubblica Ceca 44
VE - Venezuela 41
CH - Svizzera 39
SA - Arabia Saudita 38
MA - Marocco 34
UZ - Uzbekistan 34
RO - Romania 32
IR - Iran 31
TG - Togo 30
CL - Cile 28
AE - Emirati Arabi Uniti 26
PY - Paraguay 25
TN - Tunisia 24
LT - Lituania 22
PH - Filippine 22
PE - Perù 21
EG - Egitto 20
DZ - Algeria 19
UY - Uruguay 18
KE - Kenya 17
NP - Nepal 17
EU - Europa 16
IL - Israele 15
AU - Australia 14
OM - Oman 14
TH - Thailandia 14
GR - Grecia 13
KZ - Kazakistan 13
AL - Albania 12
AZ - Azerbaigian 12
JO - Giordania 12
BO - Bolivia 11
JM - Giamaica 11
KG - Kirghizistan 10
AM - Armenia 9
EE - Estonia 9
ET - Etiopia 9
LB - Libano 9
LV - Lettonia 9
MY - Malesia 9
PS - Palestinian Territory 9
DO - Repubblica Dominicana 8
BG - Bulgaria 7
TW - Taiwan 7
PA - Panama 6
RS - Serbia 6
TT - Trinidad e Tobago 6
BB - Barbados 5
BH - Bahrain 5
BY - Bielorussia 5
CR - Costa Rica 5
HN - Honduras 5
KH - Cambogia 5
LA - Repubblica Popolare Democratica del Laos 5
MD - Moldavia 5
MN - Mongolia 5
QA - Qatar 5
SN - Senegal 5
XK - ???statistics.table.value.countryCode.XK??? 5
AO - Angola 4
CI - Costa d'Avorio 4
DK - Danimarca 4
GT - Guatemala 4
HR - Croazia 4
KW - Kuwait 4
LK - Sri Lanka 4
Totale 43.310
Salva come PNG Salva come JPEG
Città #
Fairfield 2.560
Singapore 2.312
Ashburn 2.242
Woodbridge 1.761
Houston 1.283
Hong Kong 1.155
Chandler 1.120
Ann Arbor 1.010
Seattle 1.010
Beijing 943
Wilmington 931
Cambridge 854
Jacksonville 813
San Jose 630
Dearborn 547
Los Angeles 509
Boardman 455
Chicago 433
Lauterbourg 384
Ho Chi Minh City 319
Dublin 309
Princeton 298
New York 243
Council Bluffs 234
Hanoi 216
Buffalo 196
Udine 192
Dallas 186
Hefei 186
Salt Lake City 173
Helsinki 165
Munich 158
São Paulo 157
Dong Ket 145
San Diego 144
The Dalles 144
Redondo Beach 136
Seoul 133
Izmir 126
Elk Grove Village 94
Santa Clara 94
Tampa 89
Ogden 85
Des Moines 84
Frankfurt am Main 84
Tokyo 80
Nuremberg 78
Warsaw 73
Montreal 60
Orem 57
Ottawa 55
Brussels 52
Denver 52
Guangzhou 50
Norwalk 50
Brooklyn 49
Lancaster 49
London 48
Phoenix 47
Turku 47
Chennai 45
Mumbai 45
Nanjing 45
Stockholm 45
Sterling 44
Miami 43
Kunming 42
Milan 40
Rio de Janeiro 39
Baghdad 38
Belo Horizonte 38
Poplar 38
Washington 38
Amsterdam 37
Codroipo 36
Da Nang 36
Johannesburg 36
Lappeenranta 34
Trieste 34
Vienna 33
Mexico City 32
Atlanta 31
Curitiba 30
Lomé 30
Rome 30
Tashkent 30
Brno 29
Manchester 29
Redmond 29
Zurich 28
Brasília 27
Hyderabad 27
Jinan 27
Paris 27
Shanghai 27
Toronto 27
Biên Hòa 26
Düsseldorf 26
Falls Church 26
Martignacco 26
Totale 27.539
Salva come PNG Salva come JPEG
Nome #
Risks in Oncology and Radiation Therapy 681
Characterizing metastatic HER2-positive gastric cancer at the CDH1 haplotype 679
Extended Adjuvant Endocrine Treatment in Luminal Breast Cancers in the Era of Genomic Tests 479
Hepatitis B and cancer: A practical guide for the oncologist 254
In patients with metastatic breast cancer the identification of circulating tumor cells in epithelial-to-mesenchymal transition is associated with a poor prognosis 222
BNC2 is a putative tumor suppressor gene in high-grade serous ovarian carcinoma and impacts cell survival after oxidative stress 222
Bone scanning in lung cancer [2] (multiple letters) 221
The SLICE study: The prognostic role of visceral fat in metastatic colorectal cancer 211
Role of pre-surgical breast MRI in the management of invasive breast carcinoma 202
Adjuvant endocrine therapy in postmenopausal breast cancer patients: does hormone receptor status influence decision-making? 202
Expression of periostin in human breast cancer 198
First steps in the definition of a prognostic score based on MGMT methylation status in patients with glioblastoma 194
Chemotherapy in patients with early breast cancer: clinical overview and management of long-term side effects 192
Acetylation on critical lysine residues of Apurinic/apyrimidinic endonuclease 1 (APE1) in triple negative breast cancers 190
MGMT pyrosequencing-based cut-off methylation level and clinical outcome in patients with glioblastoma multiforme 188
Luminal-like HER2-negative stage IA breast cancer: A multicenter retrospective study on long-term outcome with propensity score analysis 187
Lactate Dehydrogenase (LDH) Response to First-Line Treatment Predicts Survival in Metastatic Breast Cancer: First Clues for A Cost-Effective and Dynamic Biomarker 186
Pattern of metastasis and outcome in patients with breast cancer 184
Galectin-3 expression in non-small cell lung carcinoma 182
Bevacizumab in older patients with advanced colorectal or breast cancer 181
Comparison of primary breast cancer and paired metastases: biomarkers discordance influence on outcome and therapy 180
Role of mammography, ultrasound and large-core biopsy in the diagnostic evaluation of papillary breast lesions 179
Neutrophil-to-lymphocyte and lymphocyte-to-monocyte ratios in breast cancer 179
Epigenetic bivalent marking is permissive to the synergy of HDAC and PARP inhibitors on TXNIP expression in breast cancer cells 177
BRCA2 GERMLINE MUTATIONS IN PRIMARY CANCER OF THE FALLOPIAN TUBE 177
Androgen receptor in triple negative breast cancer: A potential target for the targetless subtype 175
Mucosal Injury during Anti-Cancer Treatment: From Pathobiology to Bedside 175
Defining a prognostic score based on O6-methylguanine-DNA methyltransferase cut-off methylation level determined by pyrosequencing in patients with glioblastoma multiforme 172
Molecular diagnosis of neoplasms 171
B-cell lymphoma presenting as acute pancreatitis 171
Androgen receptor in estrogen receptor positive breast cancer: Beyond expression 170
D-dimer and venous thromboembolism 169
Bone scanning in lung cancer: pretest probability is of value 168
Magnitude of risks and benefits of the addition of bevacizumab to chemotherapy for advanced breast cancer patients: Meta-regression analysis of randomized trials. 168
Impact of hepatitis C virus infection on clinical features, quality of life and survival of patients with lymphoplasmacytoid lymphoma/immunocytoma 167
Gene expression profiling in breast cancer: a clinical perspective. 167
The prognostic performance of Adjuvant! Online and Nottingham Prognostic Index in young breast cancer patients 167
A New Genetic Risk Score to Predict the Outcome of Locally Advanced or Metastatic Breast Cancer Patients Treated With First-Line Exemestane: Results From a Prospective Study 166
Adjuvant exemestane with ovarian suppression in premenopausal breast cancer 165
Adjuvant pegylated liposomal doxorubicin for older women with endocrine nonresponsive breast cancer who are NOT suitable for a "standard chemotherapy regimen": the CASA randomized trial. 164
Measures of outcome in metastatic breast cancer: insights from a real-world scenario. 164
What does similarity mean in clinical trials? 163
Primary therapy in breast cancer: what have we learned from landmark trials? 161
Prognostic role of disease extent and lymphocyte-monocyte ratio in advanced melanoma 161
Sonographic criteria for differentiation of benign and malignant solid breast lesions: size is of value 160
Taxane-induced nail changes: incidence, clinical presentation and outcome 159
Skeletal metastases from breast cancer: pathogenesis of bone tropism and treatment strategy 159
Vaccination for seasonal influenza in patients with cancer: Recommendations of the Italian Society of Medical Oncology (AIOM) 157
Real-time tests of multiple genome alterations take the first steps into the clinic: a learning example 157
LOCALLY ADVANCED BREAST CANCER: COMPARISON OF MAMMOGRAPHY, SONOGRAPHY AND MR IMAGING IN EVALUATION OF RESIDUAL DISEASE IN WOMEN RECEIVING NEOADJUVANT CHEMOTHERAPY 157
Trastuzumab and breast cancer. Are we just beyond the prologue of a fascinating story? 157
Caring for cancer survivors: perspectives of oncologists, general practitioners and patients in Italy 156
APE1 and NPM1 protect cancer cells from platinum compounds cytotoxicity and their expression pattern has a prognostic value in TNBC 156
Treatment of metastatic breast cancer in a real-world scenario: Is progression-free survival with first line predictive of benefit from second and later lines? 155
Correlation between variation in quality of life and change in hemoglobin level after treatment with epoetin alfa 40,000 IU administered once-weekly 154
A multicentre Phase II study of non-pegylated liposomal doxorubicin in combination with trastuzumab and docetaxel as first-line therapy in metastatic breast cancer 152
TSH controls ref-1 nuclear translocation in thyroid cells 151
Evidence-based appraisal of the upfront treatment for unresectable metastatic colorectal cancer patients 151
Immunocytochemical expression of tissue specific transcription factor-1 in lung carcinoma 149
Do platinum salts fit all triple negative breast cancers? 149
Prognostic role of disease extent and lymphocyte-monocyte ratio in advanced melanoma 149
A Delphi consensus and open debate on the role of first-line bevacizumab for HER2-negative metastatic breast cancer 148
Prognostic evaluation in palliative care: final results from a prospective cohort study 148
Hot topics and landmark studies from the 43rd annual meeting of the American Society of Clinical Oncology 147
Circulating tumor DNA analysis in breast cancer: Is it ready for prime-time? 147
A risk score integrating lymphocytes ratios (LRs) and lactate dehydrogenase (LDH) levels to predict prognosis in metastatic breast cancer (MBC) patients 147
Angiogenesis and tumor growth 146
Expert pathology consultation through the Internet: melanoma versus benign melanocytic tumours 146
Predictors of axillary lymph node metastases in patients with T1 breast carcinoma 146
Dose-dense adjuvant chemotherapy in premenopausal breast cancer patients: A pooled analysis of the MIG1 and GIM2 phase III studies 146
p53 protein expression and p53 mutation in thymic epithelial tumors 145
Information to cancer patients: a questionnaire survey in three different geographical areas in Italy. 145
Looking for predictive markers in breast cancer 145
Capecitabine-induced cardiotoxicity: More evidence or clinical approaches to protect the patients' heart? 145
A TGF-β associated genetic score to define prognosis and platinum sensitivity in advanced epithelial ovarian cancer 145
The role of sidedness in second-line therapy for RAS wild-type colorectal cancer: a network meta-analysis (NMA) 145
Patterns of care and clinical outcomes of first-line trastuzumab-based therapy in HER2-positive metastatic breast cancer patients relapsing after (Neo)adjuvant trastuzumab: An Italian multicenter retrospective cohort study 145
Effect of age on hemoglobin levels and quality of life following treatment with epoetin alfa in cancer patients 144
Cognitive functions and elderly cancer patients receiving anticancer treatment: a prospective study 143
[Early breast cancer in pre-menopausal women and endocrine treatment: which factors impact on decision-making process?] 143
CDK 4/6 inhibitors as single agent in advanced solid tumors 143
Treatment of HER2-positive breast cancer: current status and future perspectives 142
Expression and localization of the homeodomain-containing protein HEX in human thyroid tumors 142
Large core biopsy for diagnostic and prognostic evaluation of invasive breast carcinomas 141
PROTEOMIC EVALUATION OF CORE BIOPSY SPECIMENS FROM BREAST LESIONS 141
MR mammography using diffusion-weighted imaging in evaluating breast cancer: a correlation with proliferation index 140
Role of Bruton's Tyrosine Kinase in Stage III Colorectal Cancer 140
Central nervous system involvement in breast cancer patients: Is the therapeutic landscape changing too slowly? 139
Adjuvant Tamoxifen Plus Ovarian Function Suppression Versus Tamoxifen Alone in Premenopausal Women With Early Breast Cancer: Patient-Reported Outcomes in the Suppression of Ovarian Function Trial 139
Body mass index and circulating oestrone sulphate in women treated with adjuvant letrozole 139
Controversies in monitoring metastatic breast cancer during systemic treatment. Results of a GIM (Gruppo Italiano Mammella) survey 139
Adjuvant endocrine therapy in premenopausal patients with hormone receptor-positive early breast cancer: Evidence evaluation and GRADE recommendations by the Italian Association of Medical Oncology (AIOM) 139
Safety Profiles and Pharmacovigilance Considerations for Recently Patented Anticancer Drugs: Cutaneous Melanoma 138
Follow-up of patients with early breast cancer: Is it time to rewrite the story? 137
First-line chemotherapy with or without biologic agents for metastatic breast cancer 136
FEASIBILITY STUDY OF A WEB APPLICATION FOR SELF-REPORT OF ANTICANCER TREATMENT TOXICITIES 136
Observational study on adjuvant trastuzumab in HER2-positive early breast cancer patients 136
Balance between cell division and cell death as predictor of survival in patients with non-small-cell lung cancer 136
Monocyte-to-lymphocyte ratio in metastatic colorectal cancer: Prognostic role evaluation and cut-off definition 136
Dramatic tumour response to pemetrexed single-agent in an elderly patient with malignant peritoneal mesothelioma: a case report 135
Totale 17.499
Salva come PNG Salva come JPEG
Categoria #
all - tutte 164.765
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 164.765
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021930 0 0 0 0 0 0 0 0 0 168 419 343
2021/20222.555 214 216 83 162 69 142 148 116 40 440 551 374
2022/20232.662 332 191 71 309 270 726 29 205 338 37 90 64
2023/20241.387 123 91 73 51 194 277 41 74 134 109 59 161
2024/20257.555 190 466 304 251 377 416 470 430 768 706 1.191 1.986
2025/202614.961 1.641 2.326 1.454 1.607 2.241 1.204 1.746 607 1.143 992 0 0
Totale 44.679